BAY 43-9006 ≥98% (by NMR)
Supplier: ADIPOGEN CORP MS
|
Warning
|
Synonyms:
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide, Sorafenib, N-[4-Chloro-3-(trifluoromethyl)phenyl]-N′-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea, 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide
AG-CR1-0025-M001
AG-CR1-0025-M005
AG-CR1-0025-M025
102515-964EA
20.77
USD
102515-964
102515-966
102515-968
BAY 43-9006 ≥98% (by NMR)
Sorafenib (BAY 43-9006)
Antitumor compound. Broad-spectrum kinase inhibitor. Raf kinase inhibitor. Apoptosis inducer. Cytostatic. Angiogenesis inhibitor. Review.
Formula:
C₂₁H₁₆ClF₃N₄O₃ MW: 464.82 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD06411450 CAS Number: 284461-73-0 |
Specification Test Results
Purity |
|
Appearance/Color | White to off-white solid. |
Solubility | Soluble in DMSO, 100% ethanol, methanol or ethyl acetate. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...